Impact Of Gene Expression Profiling Tests On Breast Cancer Outcomes

Impact Of Gene Expression Profiling Tests On Breast Cancer Outcomes Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Impact Of Gene Expression Profiling Tests On Breast Cancer Outcomes book. This book definitely worth reading, it is an incredibly well-written.

Impact of Gene Expression Profiling Tests on Breast Cancer Outcomes

Author : Luigi Marchionni
Publisher : DIANE Publishing
Page : 230 pages
File Size : 46,6 Mb
Release : 2009-05
Category : Medical
ISBN : 9781437911046

Get Book

Impact of Gene Expression Profiling Tests on Breast Cancer Outcomes by Luigi Marchionni Pdf

Assesses the evidence that three marketed gene expression-based assays improve prognostic accuracy, treatment choice, and health outcomes in women diagnosed with early stage breast cancer. Three gene expression assays were evaluated; Oncotype DX¿, MammaPrint® and the Breast Cancer Profiling (BCP or H/I ratio) test, and for gene expression signatures underlying the assays. They sought evidence on: analytic performance of tests; clinical validity; clinical utility; harms; and impact on clinical decision making and health care costs. Conclusions: Oncotype DX is furthest along the validation pathway, with retrospective evidence that it predicts distant spread and chemotherapy benefit to a clinically relevant extent over standard predictors. Illus.

Adjuvant Therapy for Breast Cancer

Author : Monica Castiglione,Martine J. Piccart
Publisher : Springer Science & Business Media
Page : 483 pages
File Size : 49,5 Mb
Release : 2009-07-11
Category : Medical
ISBN : 9780387751153

Get Book

Adjuvant Therapy for Breast Cancer by Monica Castiglione,Martine J. Piccart Pdf

Adjuvant treatment is administered prior to or as follow up to surgical procedures for breast cancer. Proven success in using medical therapies allowing for breast conserving procedures or reducing risk of occurrence. Although there has been much progress towards a cure, including the introduction of new targeted therapies, metastasizing cancer remains highly incurable.

Personalised Cancer Medicine

Author : Anne Kerr
Publisher : Unknown
Page : 280 pages
File Size : 46,5 Mb
Release : 2021-02-23
Category : Medical
ISBN : 1526141027

Get Book

Personalised Cancer Medicine by Anne Kerr Pdf

A Comparison of Gene Expression Profiling Tests for Breast Cancer

Author : Pam Smartt,Health Services Assessment Collaboration (Group)
Publisher : Unknown
Page : 102 pages
File Size : 49,7 Mb
Release : 2010
Category : Breast
ISBN : 0986456365

Get Book

A Comparison of Gene Expression Profiling Tests for Breast Cancer by Pam Smartt,Health Services Assessment Collaboration (Group) Pdf

High-Risk Cutaneous Squamous Cell Carcinoma

Author : Chrysalyne D. Schmults
Publisher : Springer
Page : 255 pages
File Size : 54,7 Mb
Release : 2016-04-29
Category : Medical
ISBN : 9783662470817

Get Book

High-Risk Cutaneous Squamous Cell Carcinoma by Chrysalyne D. Schmults Pdf

This book is a cutting-edge resource that provides clinicians with the up-to-date practical knowledge required in order to manage SCC patients optimally. It summarizes newly available information relating to the definition of high-risk SCC, its pathophysiologic underpinnings, and its management. New prognostic information and staging systems are summarized that enable high-risk tumors to be defined more precisely than ever before. Many helpful tips are provided on the practical management of challenging cases, including multiple tumors/field cancerization, high-risk tumors, nodal metastases, and unresectable disease. The authors are all acknowledged experts in the emerging field of high-risk and advanced SCC.​

Meta-Analysis of Gene Expression Profiles in Breast Cancer: Toward a Unified Understanding of Breast Cancer Subtyping and Prognosis Signatures

Author : breast breast cancer
Publisher : Unknown
Page : 40 pages
File Size : 46,9 Mb
Release : 2016-01-15
Category : Electronic
ISBN : 1523423439

Get Book

Meta-Analysis of Gene Expression Profiles in Breast Cancer: Toward a Unified Understanding of Breast Cancer Subtyping and Prognosis Signatures by breast breast cancer Pdf

Breast cancer subtyping and prognosis have been studied extensively by gene expression profiling, resulting in disparate signatures with little overlap in their constituent genes. Although a previous study demonstrated a prognostic concordance among gene expression signatures, it was limited to only one dataset and did not fully elucidate how the different genes were related to one another nor did it examine the contribution of well-known biological processes of breast cancer tumorigenesis to their prognostic performance.

Targeted Therapies for Lung Cancer

Author : Ravi Salgia
Publisher : Springer
Page : 238 pages
File Size : 52,9 Mb
Release : 2019-06-26
Category : Medical
ISBN : 9783030178321

Get Book

Targeted Therapies for Lung Cancer by Ravi Salgia Pdf

This book contextualizes translational research and provides an up to date progress report on therapies that are currently being targeted in lung cancer. It is now well established that there is tremendous heterogeneity among cancer cells both at the inter- and intra-tumoral level. Further, a growing body of work highlights the importance of targeted therapies and personalized medicine in treating cancer patients. In contrast to conventional therapies that are typically administered to the average patient regardless of the patient’s genotype, targeted therapies are tailored to patients with specific traits. Nonetheless, such genetic changes can be disease-specific and/or target specific; thus, the book addresses these issues manifested in the somatically acquired genetic changes of the targeted gene. Each chapter is written by a leading medical oncologist who specializes in thoracic oncology and is devoted to a particular target in a specific indication. Contributors provide an in-depth review of the literature covering the mechanisms underlying signaling, potential cross talk between the target and downstream signaling, and potential emergence of drug resistance.

Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?

Author : Kulmira Nurgali,R. Thomas Jagoe,Raquel Abalo
Publisher : Frontiers Media SA
Page : 245 pages
File Size : 43,9 Mb
Release : 2018-06-12
Category : Electronic
ISBN : 9782889454822

Get Book

Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae? by Kulmira Nurgali,R. Thomas Jagoe,Raquel Abalo Pdf

Advances in anti-cancer chemotherapy over recent years have led to improved efficacy in curing or controlling many cancers. Some chemotherapy-related side-effects are well recognized and include: nausea, vomiting, bone marrow suppression, peripheral neuropathy, cardiac and skeletal muscle dysfunction and renal impairment. However, it is becoming clearer that some chemotherapy-related adverse effects may persist even in long term cancer survivors. Problems such as cognitive, cardiovascular and gastrointestinal dysfunction, and neuropathy may lead to substantial long term morbidity. Despite improvements in treatments to counteract acute chemotherapy-induced adverse effects, they are often incompletely effective. Furthermore, counter-measures for some acute side-effects and many potential longer term sequelae of anti-cancer chemotherapy have not been developed. Thus, new insights into prevalence and mechanisms of cancer chemotherapy-related side effects are needed and new approaches to improving tolerance and reduce sequelae of cancer chemotherapy are urgently needed. The present Research Topic focuses on adverse effects and sequelae of chemotherapy and strategies to counteract them.

Molecular Pathology of Breast Cancer

Author : Sunil Badve,Yesim Gökmen-Polar
Publisher : Springer
Page : 428 pages
File Size : 43,8 Mb
Release : 2016-11-26
Category : Medical
ISBN : 9783319417615

Get Book

Molecular Pathology of Breast Cancer by Sunil Badve,Yesim Gökmen-Polar Pdf

The complex landscape of breast cancer requires distinct strategies for the management of various molecular subtypes of this disease. Rapid advances in the field of molecular biology have been bewildering for those involved in its study and management. “Molecular Pathology of Breast Cancer” aims to close this knowledge gap by discussing comprehensively the evolution, biological basis and clinical applications with a focus on the “what, when, and how” of the most significant molecular markers known to date. These markers are evaluated in the context of genomic, transcriptomic and proteomic profiles, which is integral to the practice of precision medicine. The application of next generation sequencing (NGS) has provided new insights in the regulation of genomic and transcriptomic structure and function. Alterations in DNA such as mutations and single nucleotide polymorphisms (SNPs) have been correlated with outcomes and provide for novel therapeutic approaches. These NGS analyses have also revealed the extensive contributions of epigenetic mechanisms such as histone modifications, non-coding RNA and alternative splicing. All of these changes together contribute to alterations in proteome. Newer assays that allow greater stability and analytical consistency are emerging. These alterations in tumor profiles can be also now detected by imaging techniques. The heterogeneity of both tumor and tumor microenvironment, an inevitable reality, is discussed in detail with particular focus on cancer stem cells and immune signaling. A chapter is dedicated to the emerging technology of “liquid biopsy”, which opens a novel approach for “continuous” monitoring of cancer that might be superior to conventional diagnostics, “Molecular Pathology of Breast Cancer” provides a quick and easy, not to mention essential, tour for clinicians, pathologists and scientists who are seeking to understand the integration of molecular biology into the diagnosis, prognosis and management of breast cancer.

Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease

Author : Institute of Medicine,Food and Nutrition Board,Board on Health Sciences Policy,Board on Health Care Services,Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease
Publisher : National Academies Press
Page : 335 pages
File Size : 40,5 Mb
Release : 2010-06-25
Category : Medical
ISBN : 9780309157278

Get Book

Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease by Institute of Medicine,Food and Nutrition Board,Board on Health Sciences Policy,Board on Health Care Services,Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease Pdf

Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process.

Breast Cancer Metastasis and Drug Resistance

Author : Aamir Ahmad
Publisher : Springer Nature
Page : 427 pages
File Size : 52,8 Mb
Release : 2019-08-27
Category : Medical
ISBN : 9783030203016

Get Book

Breast Cancer Metastasis and Drug Resistance by Aamir Ahmad Pdf

Resistance to therapies, both targeted and systemic, and metastases to distant organs are the underlying causes of breast cancer-associated mortality. The second edition of Breast Cancer Metastasis and Drug Resistance brings together some of the leading experts to comprehensively understand breast cancer: the factors that make it lethal, and current research and clinical progress. This volume covers the following core topics: basic understanding of breast cancer (statistics, epidemiology, racial disparity and heterogeneity), metastasis and drug resistance (bone metastasis, trastuzumab resistance, tamoxifen resistance and novel therapeutic targets, including non-coding RNAs, inflammatory cytokines, cancer stem cells, ubiquitin ligases, tumor microenvironment and signaling pathways such as TRAIL, JAK-STAT and mTOR) and recent developments in the field (epigenetic regulation, microRNAs-mediated regulation, novel therapies and the clinically relevant 3D models). Experts also discuss the advances in laboratory research along with their translational and clinical implications with an overarching goal to improve the diagnosis and prognosis, particularly that of breast cancer patients with advanced disease.

Oncogenomics and Cancer Proteomics

Author : Cesar Lopez-Camarillo,Elena Arechaga-Ocampo
Publisher : BoD – Books on Demand
Page : 242 pages
File Size : 54,5 Mb
Release : 2013-03-13
Category : Medical
ISBN : 9789535110415

Get Book

Oncogenomics and Cancer Proteomics by Cesar Lopez-Camarillo,Elena Arechaga-Ocampo Pdf

Oncogenomics and Cancer Proteomics - Novel Approaches in Biomarkers Discovery and Therapeutic Targets in Cancer presents comprehensive reviews of the most common cancers from bench to bedside applications by an international team of experts. This book will contribute to the scientific and medical community by providing up-to-date discoveries of oncogenomics and their potential applications in cancer translational research. It is intended for students, scientists, clinicians, oncologists and health professionals working in cancer research.

Biomarkers in Breast Cancer

Author : Giampietro Gasparini,Daniel F. Hayes
Publisher : Springer Science & Business Media
Page : 342 pages
File Size : 45,5 Mb
Release : 2008-01-17
Category : Medical
ISBN : 9781592599158

Get Book

Biomarkers in Breast Cancer by Giampietro Gasparini,Daniel F. Hayes Pdf

Expert laboratory and clinical researchers from around the world review how to design and evaluate studies of tumor markers and examine their use in breast cancer patients. The authors cover both the major advances in sophisticated molecular methods and the state-of-the-art in conventional prognostic and predictive indicators. Among the topics discussed are the relevance of rigorous study design and guidelines for the validation studies of new biomarkers, gene expression profiling by tissue microarrays, adjuvant systemic therapy, and the use of estrogen, progesterone, and epidermal growth factor receptors as both prognostic and predictive indicators. Highlights include the evaluation of HER2 and EGFR family members, of p53, and of UPA/PAI-1; the detection of rare cells in blood and marrow; and the detection and analysis of soluble, circulating markers.